In 2025, the Benelux industry totaled USD 7.96 billion.
Our forecasts suggests the Benelux Infusion Services Market at USD 18.47 billion by 2033, reflecting a CAGR of 11.1% throughout the projection period.
High biologic penetration combined with strong hospital network integration supports stable infusion volumes, with outpatient oncology pathways increasingly optimized for capacity efficiency.
Belgium’s Federal Public Service Health confirms consistent oncology treatment activity levels, sustaining demand for hospital-based infusion services across the region.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]